potassium chloride 2 MEQ/ML Injectable Solution

What the CMS Formulary Data Shows for potassium chloride 2 MEQ/ML Injectable Solution

Per the CMS 2026 Part D formulary file, potassium chloride 2 MEQ/ML Injectable Solution (RxNorm concept RXCUI 204520, generic name potassium chloride) appears on 306 distinct formulary files spanning 4,902 Medicare Part D plan offerings - 96.7% of enrollable Part D products, near-universal placement. Tier placement ranges from Tier 1 to Tier 6, with a cross-plan average of Tier 2.5.

Real-world access to potassium chloride 2 MEQ/ML Injectable Solution depends on utilization management as much as tier placement: 1.3% of covering formularies require prior authorization. 0% require step therapy. 0% apply quantity limits.

Historical spending context from the CMS Medicare Part D Drug Spending Dashboard shows 3,479,756 Part D beneficiaries filled potassium chloride 2 MEQ/ML Injectable Solution in 2023, with total plan-and-beneficiary spending of $396,202,925 and an average per-beneficiary annual cost of $113.86. The plan-by-plan detail below lists exactly which PDP and MA-PD contracts carry potassium chloride 2 MEQ/ML Injectable Solution today.